Implementation of the International Classification of Functioning, Disability and Health Model in Paediatric Cochlear Implant Recipients

NCT ID: NCT06841900

Last Updated: 2025-02-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-03-31

Study Completion Date

2027-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to implement the International Classification of Functioning, disability and health (ICF) in paediatric Cochlear Implant (CI) recipients (\<18 years) with prelingual sensorineural hearing loss in a multicenter prospective study to evaluate audiological rehabilitation after cochlear implantation. For this, ICF qualifiers which denote the magnitude of the level of health or severity of the problem will be quantified. Outcome measures include four questionnaires and three standard audiological examinations. Subjects will be assessed up to 1 month before implantation and 3 months, 6 months and 1 year post the activation of the speech processor.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cochlear Impant Children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cochlear Implant (CI) recipients (<18 years) with prelingual sensorineural hearing loss

Cochlear Implant (CI) recipients (\<18 years) with prelingual sensorineural hearing loss

Cochlear Implantation

Intervention Type DEVICE

Standard cochlear implantation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cochlear Implantation

Standard cochlear implantation

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

General

* Children aged \< 18 years with prelingual bilateral severe-to-profound HL
* Signed and dated informed consent, informed permission and/or minor's assent.
* Willingness to participate in evaluations, test sessions, and medical follow-up sessions as defined in the protocol.
* Physical and mental competence to participate in fitting of the device and follow-up sessions as defined in the protocol.

Audiological

* Completion of hearing assessment battery showing suitability of the CI candidates.
* Compliance with cochlear implant candidate selection criteria of the implanting centre.
* First cochlear implantation Medical
* Patent cochlea, as evidenced by High-resolution computed tomography (HRCT) and/or Magnetic Resonance Imaging (MRI).

Exclusion Criteria

General

* Re-implantation of the cochlear implant
* No motivation to participate in the study and/or unreasonable expectations. Medical
* Presence of contra-indications for surgery in general and cochlear implantation in particular.
* Presence of central auditory lesions.
* Any disorder that may relate to an increased risk of skin flap problems Use of one of the following electrodes for implantation
* Compressed
* Split
* Any type of custom made electrodes
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Antwerp

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fiona Stanley Fremantle Hospital Group

Perth, , Australia

Site Status

University Hospital Antwerp

Edegem, , Belgium

Site Status

University Clinic of Würzburg

Würzburg, , Germany

Site Status

World Hearing Centre

Warsaw, , Poland

Site Status

King Abdullah Ear Specialist Center (KAESC)

Riyadh, , Saudi Arabia

Site Status

Hospital La Paz

Madrid, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Australia Belgium Germany Poland Saudi Arabia Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ellen Andries, PhD AUD

Role: CONTACT

+32 3 275 7372

Griet Mertens, PhD AUD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dayse Tavora-Viera

Role: primary

+61 8 6488 4880

Ellen Andries

Role: primary

+32 3 275 7372

Griet Mertens

Role: backup

Anja Kurz

Role: primary

+49 - 931 201 21701

Artur Lorens

Role: primary

954-404-6477

Medhat Yousef

Role: primary

+966 1 4670888

Miryam Calvino

Role: primary

+34 917 27 70 00

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ICF in Paediatric CI users

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hear Again, Work Again
NCT05196022 RECRUITING